MetaCap

Oncolytics Biotech (ONCY) vs OS Therapies (OSTX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

OS Therapies (OSTX) has outperformed Oncolytics Biotech (ONCY) over the past year, losing 24.0% versus a loss of 55.9%. OS Therapies is the larger company by market cap ($73.9 million vs $72.8 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ONCY-55.87%OSTX-24.02%
+13%-23%-59%
Oct 7, 20251 yearOct 7, 2026
ONCY-41.59%OSTX-61.25%
+41%-18%-76%
Jul 29, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ONCY versus OSTX key metrics
MetricONCYOSTX
Share price$0.5551$1.58
Market cap$72.79M$73.95M
1-day change-6.83%+1.93%
YTD return-31.52%+10.71%
1-year return-55.87%-24.02%
5-year return-73.16%—
Forward P/E—4.56
EPS (TTM)$-0.35$-1.08
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.32$2.25
52-week low$0.555$1.15
Distance from 52-week high-57.95%-29.78%
Average volume1.10M597.09K
Shares outstanding131.12M46.81M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OSTX has outperformed ONCY by 31.8 percentage points over the past year.

ONCY vs OSTX FAQ

Which is bigger, Oncolytics Biotech or OS Therapies?

OS Therapies (OSTX) is larger, with a market capitalization of $73.95M compared with $72.79M for Oncolytics Biotech (ONCY).

Which stock has performed better over the past year, ONCY or OSTX?

OSTX returned -24.02% over the past 12 months, compared with -55.87% for ONCY (price return, excluding dividends). Past performance does not predict future results.

Are Oncolytics Biotech and OS Therapies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons